Interpretable machine learning models for survival prediction in prostate cancer bone metastases.

Sci Rep · 2025 · PMC12230155 · PMID 40619463

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Analysis of treatment combinations revealed that dual therapies including chemotherapy + radiotherapy (median survival 43.0 months, p = 0.079), surgery + chemotherapy (47.0 months), and surgery + radiotherapy (45.0 months) showed trends toward improved survival but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.